Calculates CrCl according to the Cockcroft-Gault equation.

Calculates mean arterial pressure.

Corrects the QT interval for heart rate extremes (choose from Bazett, Fridericia, Framingham, Hodges, or Rautaharju formulas)

Determine 10-year risk of hard ASCVD, i.e. myocardial infarction, stroke, or death due to coronary heart disease or stroke

Predicts 10- and 30-year risk of CVD and CVD subtypes in patients aged 30-79 without known CVD.

Predicts 6-week risk of major adverse cardiac events in patients with chest pain.

Estimates admission to 6 month mortality for patients with acute coronary syndrome.

Predicts mortality risk in STEMI patients.

Calculates stroke risk for patients with atrial fibrillation.

Estimates risk of major bleeding for patients on anticoagulation to assess risk-benefit in atrial fibrillation care.

Determines bleeding risk for patients on warfarin.

Estimates risk of cardiac complications after noncardiac surgery.

Estimates 10-year risk of heart attack in patients 30-79 years with no history of CHD or diabetes.

Predicts 10-year CVD risk in patients without prior CVD or diabetes.

Estimates 1- and 3- year mortality in heart failure.

Calculates pre-test probability of PE to determine next steps in evaluation.

Calculates cardiac output, cardiac index, and stroke volume.

Predicts risk of MI or cardiac arrest after surgery.

Diagnostic criteria for infective endocarditis.

Describes stages of heart failure and provides recommendations for therapy by stage.

Predicts 30-day mortality after elective or emergency cardiac surgery.

Predicts risk of NSTEMI complications requiring ICU care.

Predicts in-hospital mortality in patients with heart failure (HF).

Assesses chest pain patients at 2 hours for risk of cardiac event.

Adjusts D-dimer cutoffs to help rule out VTE in patients ≥50 years old.

Rules out PE if no criteria are present; includes SaO2 adjustment for altitude.

Stratifies cardiovascular risk of patients undergoing noncardiac surgery.

Assigns phenotype in patients with ischemic stroke of uncertain causes.

Predicts 90-day poor outcome in patients with acute ischemic stroke.

Determines stroke risk in patients with atrial fibrillation.

Distinguishes ventricular tachycardia from supraventricular tachycardia.

Predicts poor prognosis after out-of-hospital cardiac arrest and guides utility of cardiac catheterization

Classifies severity of angina

Predicts 30-day serious adverse events in patients presenting with syncope.

Identifies risk of stroke in the next 7 days in patients who experienced symptoms of TIA.

A simple, clinically derived ordinal classification system that predicts morbidity and mortality after cardiac surgery.

Calculates rate of energy output of the h

Predicts cardiovascular risk in orthotopic liver transplantation (OLT).

Predicts risk of in-hospital cardiac arrest.

Guides antithrombotic therapy for patients with nonvalvular atrial fibrillation or atrial flutter.

Estimates stroke risk in patients with atrial fibrillation.

Calculates stroke risk for patients with atrial fibrillation; similar to the CHA₂DS₂-VASc Score but without considering sex.

Predicts large vessel occlusion (LVO) and severe stroke in patients with stroke symptoms.

Stratifies risk of normotensive shock in patients with pulmonary embolism (PE).

Provides inclusion/exclusion criteria for IVT in acute ischemic stroke patients.

Evaluates bone marrow response to anemia, often in sickle cell patients.

Stratifies bleeding risk after NSTEMI.

Predicts likelihood of recurrence of first VTE.

Predicts bleeding risk in patients with atrial fibrillation on DOAC.

Predicts which patients will benefit from prolonged DAPT after coronary stent placement.

Estimates functional capacity.

Diagnostic criteria for endocarditis.

Diagnoses and prognoses suspected CAD based on the treadmill exercise test.

Identifies chest pain patients with low risk of major adverse cardiac event.

Estimates 7-day mortality of emergency HF patients.

Determines risk of right ventricular HF in patients after LVAD implantation.

Predicts risk of in-hospital mortality after major cardiac surgery.

Diagnoses heart failure based on major and minor criteria.

Predicts mortality, stroke, and bleeding in patients w/ and w/out anticoagulation.

Predicts need for VTE prophylaxis in admitted patients.

Objectifies risk of PE, like Wells' score.

Classifies prognosis of patients with transthyretin amyloid cardiomyopathy.

Predicts survival to discharge with good outcome after in-hospital cardiac arrest.

Classifies prognosis of patients with wild-type transthyretin amyloid cardiomyopathy.

Predicts in-hospital all-cause heart failure mortality.

Estimates probability of underlying heart failure in patients with preserved ejection fraction on echo.

Predicts failure of noninvasive ventilation (NIV) in hypoxemic patients.

Estimates risk of sudden cardiac death in patients with hypertrophic cardiomyopathy.

Stratifies the risk of NSTEMI and evaluates the necessity of troponin measurement.

Identifies emergency department patients with acute chest pain for early discharge.

Quantifies risk of hemorrhage in elderly patients with AFib.

Identifies low-risk PE patients safe for outpatient treatment.

Stratifies cardiotoxicity risk in cancer patients scheduled to receive anthracycline-based chemotherapy.

Stratifies cardiotoxicity risk in cancer patients scheduled to receive combination RAF and MEK inhibitors.

Stratifies cardiotoxicity risk in cancer patients scheduled to receive HER2-targeted therapies.

Stratifies cardiotoxicity risk in CML cancer patients scheduled to receive BCR-ABL TKIs.

Stratifies cardiotoxicity risk in cancer patients scheduled to receive multiple myeloma therapies.

Stratifies cardiotoxicity risk in cancer patients scheduled to receive VEGF inhibitor therapy.

Stratifies ACS risk with history and EKG only (not yet externally validated).

Predicts survival following rewarming of hypothermic cardiac arrest patients.

Predicts risk of venous thromboembolism (VTE) in multiple myeloma.

Predicts 3-month risk of VTE in hospitalized patients.

Predicts risk of VTE in hospitalized patients, adding D-dimer to IMPROVE Risk Score.

Differentiates between active and inactive disease in Takayasu arteritis (TAK).

Predicts mortality at 6 months in patients with infective endocarditis.

Rules out coronary artery disease (CAD) in primary care patients with chest pain.

Diagnoses overt disseminated intravascular coagulation (DIC).

Diagnoses Kawasaki Disease.

Quantifies severity of heart failure in ACS and predicts 30-day mortality.

Predicts 30-day readmission or death in patients on medicine and surgery wards

Rules out coronary artery disease in primary care patients with chest pain.

Estimates LDL-C from a standard lipid profile using an adjustable triglyceride:VLDL-C ratio.

Predicts risk of contrast-induced nephropathy (CIN) after percutaneous coronary intervention (PCI).

Predicts risk of type 2 diabetes in previously undiagnosed patients.

Modified Sgarbossa's Criteria for MI in Left Bundle Branch Block

Predicts short-term mortality in acute ischemic stroke.

Predicts the natriuretic response to intravenous loop diuretics

Stratifies severity of heart failure by symptoms.

Rules out need for chest x-ray in chest pain patients (non-traumatic).

Stratifies risk of in-hospital cardiogenic shock in patients undergoing primary percutaneous coronary intervention (PCI).

Estimates 12-month all-cause mortality in patients presenting with syncope.

Predicts bleeding risk in patients on anticoagulation for afib, similar to HAS-BLED.

Identifies ED patients with heart failure at high risk for serious adverse events.

Identifies pediatric patients at risk for clinical deterioration.

Assesses stroke causality due to patent foramen ovale (PFO) by combining RoPE Score and high-risk features.

Predicts mortality and severe disability in acute ischemic stroke.

Estimates 10-year risk of incident heart failure in asymptomatic adults.

Estimates out-of-hospital bleeding risk in patients treated with dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI).

Predicts sudden cardiac death (SCD) risk in pediatric patients with hypertrophic cardiomyopathy (HCM)

Assesses the risk of right ventricular dysfunction in patients with acute inferior wall myocardial infarction and after left ventricular assist device implantation.

Predicts 30-day readmission risk in patients admitted for ST-elevation myocardial infarction (not externally validated).

Predicts the probability of death for adult extracorporeal cardiopulmonary resuscitation (ECPR).

Predicts survival in patients with pulmonary arterial hypertension.

Estimates 10-year cardiovascular risk in women over age 45 years.

Predicts adverse pulmonary outcomes from rib fracture.

Determine the risk of major bleeding during anticoagulant therapy.

Identifies stroke-related PFO in patients with cryptogenic stroke.

Predicts perioperative mortality in patients with active left-sided endocarditis.

Estimates LDL-C in patients with a low LDL-C level and/or hypertriglyceridemia.

Predicts risk for serious outcomes at 7 days in patients presenting with syncope or near-syncope.

Predicts in-hospital survival in adult patients after VA ECMO for refractory cardiogenic shock

Predicts survival in heart failure.

Predicts adverse outcomes in critically ill rib fracture patients.

Calculates the risk of in-hospital cardiogenic shock in patients with acute coronary syndrome (ACS).

Criteria to diagnose acute MI in patients with prior LBBB.

Stratifies risk in suspected Brugada syndrome.

Predicts 30-day outcome of patients with PE, with fewer criteria than the original PESI.

Diagnoses acute heart failure with NT-proBNP in undifferentiated dyspneic patients.

Predicts morbidity in patients with blunt chest wall trauma.

Differentiates normal variant ST elevation (benign early repolarization) from anterior STEMI, more sensitive than 3-variable version.

Predicts 10-year CVD risk in patients without prior CVD or diabetes.

Predicts 10-year CVD risk in patients with type 2 diabetes.

Predicts 10-year CVD risk in older patients.

Doses tenecteplase (a type of tPA) for use in ischemic stroke.

Predicts risk of VTE in patients with lower limb trauma.

Provides mortality estimate in patients with ACS using only blood pressure, heart rate, and age.

Estimates mortality in patients with STEMI.

Estimates mortality for patients with unstable angina and non-ST elevation MI.

Predicts risk of QT prolongation greater than 500 msec in hospitalized patients.

Calculates alteplase dosing for ischemic stroke

Rules out acute coronary syndrome.

Calculates urine output over a 24-hour period.

Identifies chest pain patients who are low risk and safe for early discharge.

Stratifies severity of post-thrombotic syndrome in lower extremity DVT.

Estimates risk of infective endocarditis (IE) and determines priority for echocardiography.

Assesses risk of bleeding while on anticoagulation.

Helps rule out pulmonary embolism (PE) in adult pregnant and non-pregnant patients.

Calculates risk of DVT based on clinical criteria.

Rules out PE if no criteria are present and pre-test probability is ≤15%.

Calculates maintenance fluid requirements by weight.

Determines if pleural fluid is exudative or transudative.

Predicts 30-day outcome of patients with pulmonary embolism.

Rules out PE based on clinical criteria.

Calculates reference values for distance walked, as a measure of functional status.

Diagnoses hypertension in pediatric patients; official guideline of the American Academy of Pediatrics.

Predicts 10-year survival in patients with multiple comorbidities.

Determines anticoagulation need in hospitalized patients by risk of VTE.